K

KeyNeurotek Pharmaceuticals

50 employees

KeyNeurotek is focused on developing small molecule drugs for the treatment of neuronal and autoimmune diseases.

Basic info

Industry

business consulting and services

Sectors

Biotechnology
Health Diagnostics
Medical

Date founded

2012

Funding rounds raised

Total raised

$11M

from 3 investors over 3 rounds

K

KeyNeurotek Pharmaceuticals raised $11M on April 7, 2009

Investors: IBG Beteiligungsgesellschaft, DVC Deutsche Venture Capital and KfW

FAQ